All Articles

With a proven record in biosimilars, new President Dominic Bégin is set to deepen Organon's impact on women's health and healthcare affordability in Canada.

A new survey reveals a rare bipartisan consensus on financial privacy, creating market pressure on banks and big tech to innovate or risk losing customers.

A look at how a national car wash chain’s local renovations in Kentucky are part of a larger corporate reset, blending high-tech service with deep community ties.

NRG Energy's latest dividend isn't just a shareholder reward; it's a calculated signal of financial discipline and strategic confidence in a shifting energy sector.

As prediction markets boom to $44B monthly, most trades are illiquid. Intellistake's strategic pivot with its Gravity tech aims to fix this deep-seated issue.

Beyond the headlines of a dramatic profit swing, Healthcare Services Group's Q2 results reveal a playbook on operational mastery and shrewd capital deployment.

IDC names SPS a leader, but the real story is how AI and integrated strategy are turning the humble mailroom into a strategic hub for global business.

Stearns & Foster, a brand synonymous with handcrafted luxury since 1846, is betting its future on a fusion of heritage and science. Is this the answer to our sleep crisis?

As Frontier prepares its Q2 results, a strategic shift is underway. Can First Class seats and Wi-Fi coexist with an ultra-low-cost model? All eyes are on ULCC.

As ACCO Brands preps its Q2 report, investors seek clues on hybrid work, gaming, and back-to-school trends. Can strategic acquisitions offset economic headwinds?

A new AI tool is replacing spreadsheets, helping firms make faster, data-backed decisions on when to replace vehicles, saving millions in the process.

A new AI-driven test from BRAINBox Solutions combines blood analysis and cognitive data, promising to finally replace guesswork in concussion diagnosis.

A new partnership between Evogene and ELEO leverages AI and natural product science to create an oral PCSK9 inhibitor, aiming to disrupt a $23B market.

By appointing its first Chief People Officer from the world of high-growth retail, Spear Therapy is betting that employee experience is the key to scaling patient care. Here’s the strategic rationale.

In a strategic power play, NOVAGOLD is taking full ownership of Donlin Gold, forming a new US-based titan to develop America's largest gold mine.

With an oversubscribed $130M Series B, Crystalys Therapeutics is accelerating its gout drug, dotinurad. But can it win the race to serve millions?

With 61% of its students being the first in their families to attend college, Goodwin's new initiatives offer more than support—they offer a national blueprint.

A new alliance between Pentera and Recorded Future bridges the critical gap between threat intelligence and security validation, turning data into defense.

When a hospital's diagnostic system fails, the cost is human. A $2.1M verdict reveals how a breakdown in this invisible network led to a preventable death.

As TuHURA Biosciences takes the stage at a key investor conference, its multi-pronged attack on immunotherapy resistance faces a critical test.